Use of the VisuMax™ Femtosecond Laser

PHASE1CompletedINTERVENTIONAL
Enrollment

357

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Myopia
Interventions
DEVICE

Treatment with the VisuMax™ Femtosecond Laser

The reduction or elimination of myopia from ≥ -1.00 D to ≤ -8.00 D with ≤ -0.50 D cylinder and MRSE ≤ -8.25 D.

Trial Locations (5)

33136

Bascom Palmer Eye Institute, Miami

53717

Davis Duehr Dean, Madison

57108

Vance Thompson Vision, Sioux Falls

66211

Discover Vision Centers, Leawood

80111

Dishler Laser Institute, Greenwood Village

Sponsors
All Listed Sponsors
lead

Carl Zeiss Meditec, Inc.

INDUSTRY

NCT01638390 - Use of the VisuMax™ Femtosecond Laser | Biotech Hunter | Biotech Hunter